'Tri'Ing to Clip the Gap: Percutaneous Tricuspid Intervention in a Heart Transplant

N. Gorrie,N. Bart,D. Muller
DOI: https://doi.org/10.1016/j.healun.2023.02.477
IF: 13.569
2023-04-01
The Journal of Heart and Lung Transplantation
Abstract:Introduction Tricuspid valve regurgitation (TR) is the most common valvular pathology post orthotopic heart transplant (OHT), affecting 84% of cases. Morbidity and mortality is increased in the 34% with moderate to severe TR. The multiple aetiologies include primary; anastomotic technique (bicaval superior to biatrial), biopsy related, and secondary pathologies; enlarged atria, changes from high pulmonary vascular resistance (PVR). Surgical intervention has not shown survival benefit in OHT with risks of sternal re-entry, immunosuppression and infection. Secondary TR outcomes are poor, particularly with impaired right ventricular (RV) function or elevated PVR. Novel percutaneous interventions offer an opportunity for surgically ineligible patients with refractory symptoms. This is the first reported case of TriClip in OHT. Case Report A 74 year old man was seen with refractory heart failure (NYHA Class IV) and torrential TR, with an OHT 27 years prior for dilated cardiomyopathy. He had dialysis dependant renal failure, atrial fibrillation and gout. An echocardiogram (TTE) showed severe RV dilation with normal function and diastolic interventricular flattening consistent with torrential TR. Transoesophageal echocardiogram (TOE) showed normal TV structure with functional TR due to annular dilatation, chiefly the posteroseptal commissure. Surgery was considered too high risk and percutaneous intervention approved by complex cardiac meeting. Two XT TriClips were placed in the posteroseptal coaptation defect via 6Fr right femoral vein access and TOE guidance. Post placement, TTE showed a 2 TR severity grade improvement. There was marked symptom improvement (NYHA Class II) and 4kg diuresis. He is alive at 11 months. The 2 TR grade reduction with symptomatic improvement was a successful result. The TriClip TRILUMINATE study also showed further TR grade improvement at 1 year. This case demonstrates if anatomically appropriate, in the OHT population percutaneous TR management with TriClip is a feasible.
surgery,cardiac & cardiovascular systems,respiratory system,transplantation
What problem does this paper attempt to address?